Sodexo SA (0J3F)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 56.58 |
|---|---|
| 52-week range | 35.54 – 59.20 |
| Return, 1 month / 3 months | −1.0% / +6.9% |
| Return, 1 year / 3 years | +12.1% / −29.5% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 27.6% |
| Worst drawdown (1 year) | -26.7% |
| Average daily value traded | 0.56M EUR |
| Dividend yield | 4.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sodexo is a French services company that provides food and facilities management to organisations around the world. Its catering operations run staff restaurants, hospital meals, school dining and food at remote industrial sites, while its facilities arm handles cleaning, maintenance, reception and workplace support. Customers include businesses, healthcare providers, schools, universities, defence sites and sports and leisure venues. The company is based in France and works across many countries through local operating units.
Sodexo SA trades under the code 0J3F on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sodexo SA (0J3F) trades on the London Exchange in UK. It last closed at EUR 56.58 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 634 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.1% and over the last three months it rose 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.7% | ||
| From 52-week high | -3.7% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.9% | ||
| 6-month return | 31.8% | ||
| 12-month return, skipping the last month | 13.1% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.7% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.56M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | −1.0% |
| 3 months | +6.9% |
| 6 months | +31.8% |
| 1 year | +12.1% |
| 3 years | −29.5% |
| 5 years | −2.2% |
Signals
| 50-day / 200-day average | 56.48 / 49.34 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Dec 2025 | EUR 2.7000 |
| 19 Dec 2024 | EUR 2.6500 |
| 27 Aug 2024 | EUR 6.2400 |
| 20 Dec 2023 | EUR 2.2554 |
| 23 Dec 2022 | EUR 1.7461 |
| 17 Dec 2021 | EUR 1.4551 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.